A pilot study of long-acting octreotide for symptomatic malignant ascites.

Aminah Jatoi,Jorge Nieva,Rui Qin,Charles Lawrence Loprinzi,Edward J. Wos,Paul J. Novotny,Dennis F. Moore,Rex B. Mowat,Naftali Bechar,Eduardo R. Pajon,Lynn C. Hartmann

A pilot study of long-acting octreotide for symptomatic malignant ascites.

2012

Aminah Jatoi
Jorge Nieva
Rui Qin
Charles Lawrence Loprinzi
Edward J. Wos
Paul J. Novotny
Dennis F. Moore
Rex B. Mowat
Naftali Bechar
Eduardo R. Pajon
Lynn C. Hartmann

Background: Effective, non-invasive, palliative strategies for symptomatic malignant ascites are unavailable. This trial explored whether octreotide, an inhibitor

Keywords:

Pathology
Gastroenterology
Ascites
Octreotide
Medicine
Paracentesis
Peritoneal Neoplasm
Internal medicine
Surgery
Vascular endothelial growth factor A
long acting
Diabetes mellitus
Quality of life

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations